Foghorn Therapeutics Inc (FHTX)
8.75
+0.51
(+6.19%)
USD |
NASDAQ |
Nov 05, 14:49
Foghorn Therapeutics Profit Margin (Quarterly): -333.6% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -333.6% |
| March 31, 2024 | -495.4% |
| December 31, 2023 | -417.9% |
| September 30, 2023 | -82.07% |
| June 30, 2023 | -526.6% |
| March 31, 2023 | -574.3% |
| December 31, 2022 | -690.4% |
| September 30, 2022 | -388.4% |
| Date | Value |
|---|---|
| June 30, 2022 | -608.3% |
| March 31, 2022 | -686.6% |
| December 31, 2021 | -4.09K% |
| September 30, 2021 | -63.61K% |
| June 30, 2021 | -8.28K% |
| March 31, 2021 | -8.04K% |
| December 31, 2020 | -8.27K% |
| September 30, 2020 | -10.26K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-63.61K%
Minimum
Sep 2021
-82.07%
Maximum
Sep 2023
-6.71K%
Average
-647.4%
Median
Profit Margin (Quarterly) Benchmarks
| Sana Biotechnology Inc | -- |
| Omega Therapeutics Inc | -764.1% |
| Moderna Inc | -578.7% |
| Corcept Therapeutics Inc | 25.86% |
| Akebia Therapeutics Inc | -19.66% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -28.39% |
| Operating Margin (Quarterly) | -351.8% |
| Return on Net Operating Assets | -204.6% |